{"symbol": "ESPR", "companyName": "Esperion Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.esperion.com", "description": "Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.", "CEO": "Timothy M. Mayleben", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}